文獻(xiàn)標(biāo)題: 1. Dutasteride in Androgenetic Alopecia: An Update 2. Identification of 5α-reductase isoenzymes in canine skin 3. 5α-reductases in human physiology: an unfolding story 4. Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride 5.Real-world clinical experience of amlodipine/ valsartan and amlodipine/ valsartan/hydrochlorothiazide in hypertension: the EXCITE study 6.Real-world effectiveness of amlodipine/alsartan and amlodipine/alsartan/hydrochlorothiazide in high-risk patients and other subgroups 要求: 將上述標(biāo)題文獻(xiàn)PDF格式打包上傳   [更多]

求購(gòu)“Aminohippurate Sodium Injection.”《USP32-NF27》的美國(guó)最新藥典標(biāo)準(zhǔn)一份.   [更多]

題目： Lyoc (Lyophilized Wafer): An orally disintegrating tablet technology 作者 ：S Fulzele ， D Moe ， E Hamed 出版源 《Drug Dev Del》 , 2012 鏈接 http://xueshu.baidu.com/s?wd=Lyoc+%28Lyophilized+Wafer%29%3A+An+orally+disintegrating+tablet+technology&rsv_bp=0&tn=SE_baiduxueshu_c1gjeupa&rsv_spt=3&ie=utf-8&f=8&rsv_sug2=0&sc_f_para=sc_tasktype%3D%7BfirstSimpleSearch%7D&rsv_n=2   [更多]

標(biāo)題： 1.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men 作者：Azuma, Junichi 1;Fukase, Hiroyuki 2 刊名：Clinical Pharmacology in Drug Development 出版日期：2013 期號(hào)：No.4 卷號(hào)：Vol.2 2.Pharmacokinetic evaluation of fosaprepitant dimeglumine 作者：Colon-Gonzalez F;Kraft WK. 刊名：Expert Opinion on Drug Metabolism and Toxicology 出版日期：2010 期號(hào)：No.10 卷號(hào)：Vol.6 3.Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects 作者：Dr Thomas C. Marbury MD1,*;Ms Phung L. Ngo MS2;Mr Craig R. Shadle MS2;Dr Bo Jin PhD2;Ms Deborah Panebianco MS2;Dr Luzelena Caro PhD2;Dr Jack Valentine PhD2,3;Dr Gail Murphy MD2 刊名：J Clin Pharmacol 出版日期：2011 卷號(hào)：Vol.51 4.A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects 作者：Craig R. Shadle1,*;M. Gail Murphy1;Yang Liu2;Maureen Ho1;Daniel Tatosian3;Susie (Xiujiang) Li3;Robert A. Blum4 刊名：Clinical Pharmacology in Drug Development 出版日期：2012 期號(hào)：No.3 卷號(hào)：Vol.1 5.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy 作者：Bernardo Rapoport;Teresa Smit 刊名：Expert Opinion on Drug Safety 6.Aprepitant and Fosaprepitant Drug Interactions: A Systematic Review. 作者：Patel P;Leeder JS;Piquette-Miller M;Dupuis LL. 刊名：Br J Clin Pharmacol 出版日期：2017 7.Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects. 作者：Dr Kenneth C. Lasseter MD1,*;Dr Jay Gambale PharmD2;Dr Bo Jin PhD2;Dr Art Bergman PhD2;Mr Marvin Constanzer MS2;Mr James Dru MS2;Dr Tae H. Han PhD2;Dr Anup Majumdar PhD2;Dr Judith K. Evans MD2;Dr M. Gail Murphy MD2 刊名：The Journal of Clinical Pharmacology 出版日期：2007 期號(hào)：NO.7 卷號(hào)：Vol.47 8.Prevention of chemotherapy-induced nausea and vomiting:focus on fosaprepitant 作者：Ian N Olver 刊名：Ther Clin Risk Manag 出版日期：2008 期號(hào)：No.2 卷號(hào)：Vol.4   [更多]

檢索目的: 尋求硫代縮酮的還原脫硫方法及其相關(guān)的合成路線和文獻(xiàn)資料 檢索方式: 任意數(shù)據(jù)庫(kù) 關(guān)鍵詞: 硫代縮酮的還原脫硫方法   [更多]

蒙脫石混懸液進(jìn)口注冊(cè)標(biāo)準(zhǔn)（標(biāo)準(zhǔn)號(hào)：JX20220001）   [更多]

具體要求：需要“2.6.15. Prekallikrein activator”《 EP9.2 》的歐洲藥典標(biāo)準(zhǔn)，如有符合要求的信息者，請(qǐng)留下你的聯(lián)系方式，本人會(huì)不定期的來(lái)檢查，謝謝。   [更多]

“Hydrazine sulfate.”《 EP9.2 》的藥典標(biāo)準(zhǔn)一份，包括詳細(xì)的檢測(cè)方法。   [更多]

替加環(huán)素EP最新標(biāo)準(zhǔn)1份   [更多]

作者:G Hübener 1, W G?hring, H J Musiol, L Moroder文題:N alpha-trifluoroacetylation of N-terminal hydroxyamino acids: a new side reaction in peptide synthesis期刊名:Pept Res . Sep-Oct 1992;5(5):287-92.期刊年份:Pept Res . Sep-Oct 1992;5(5):287-92.卷(期),起止頁(yè)碼:Pept Res . Sep-Oct 1992;5(5):287-92.Doi:https://pubmed.ncbi.nlm.nih.gov/1450523/全文鏈接:https://pubmed.ncbi.nlm.nih.gov/1450523/數(shù)據(jù)庫(kù)名稱:其它外文期刊   [更多]